Back to Search
Start Over
Subcutaneous insulin-like growth factor-1 treatment in spinocerebellar ataxias: an open label clinical trial.
- Source :
-
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2011 Feb 01; Vol. 26 (2), pp. 358-9. Date of Electronic Publication: 2010 Oct 19. - Publication Year :
- 2011
- Subjects :
- Adult
Analysis of Variance
Humans
Injections, Subcutaneous
Insulin-Like Growth Factor I administration & dosage
Prospective Studies
Recombinant Proteins administration & dosage
Treatment Outcome
Insulin-Like Growth Factor I therapeutic use
Recombinant Proteins therapeutic use
Spinocerebellar Ataxias drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1531-8257
- Volume :
- 26
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Movement disorders : official journal of the Movement Disorder Society
- Publication Type :
- Report
- Accession number :
- 20960476
- Full Text :
- https://doi.org/10.1002/mds.23423